• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Neutralizing antibody blocks adenovirus infection by arresting microtubule-dependent cytoplasmic transport.中和抗体通过阻止微管依赖性细胞质运输来阻断腺病毒感染。
J Virol. 2008 Jul;82(13):6492-500. doi: 10.1128/JVI.00557-08. Epub 2008 Apr 30.
2
Postentry neutralization of adenovirus type 5 by an antihexon antibody.抗六邻体抗体对5型腺病毒的感染后中和作用
J Virol. 2004 Nov;78(22):12320-32. doi: 10.1128/JVI.78.22.12320-12332.2004.
3
Complement component C1q and anti-hexon antibody mediate adenovirus infection of a CAR-negative cell line.补体成分C1q和抗六邻体抗体介导腺病毒对CAR阴性细胞系的感染。
Viral Immunol. 2008 Dec;21(4):469-76. doi: 10.1089/vim.2008.0032.
4
A novel human monoclonal antibody potently neutralizes human adenovirus serotype 7 by primarily targeting the adenovirus hexon protein.一种新型人源单克隆抗体主要通过靶向腺病毒六邻体蛋白来有效中和人腺病毒 7 型。
Virology. 2020 Apr;543:20-26. doi: 10.1016/j.virol.2019.12.005. Epub 2019 Dec 12.
5
Generation of neutralizing monoclonal antibodies against a conformational epitope of human adenovirus type 7 (HAdv-7) incorporated in capsid encoded in a HAdv-3-based vector.针对基于人腺病毒3型(HAdv-3)载体编码的衣壳中包含的人腺病毒7型(HAdv-7)构象表位产生中和性单克隆抗体。
PLoS One. 2014 Jul 23;9(7):e103058. doi: 10.1371/journal.pone.0103058. eCollection 2014.
6
Epitope mapping and characterization of a neutralizing monoclonal antibody against human adenovirus type 3.针对人腺病毒 3 型的中和性单克隆抗体的表位作图和鉴定。
Virus Res. 2013 Nov 6;177(2):189-93. doi: 10.1016/j.virusres.2013.08.013. Epub 2013 Sep 7.
7
Detection of subtle differences in analogous viral capsid proteins by allowing unrestricted specific interaction in solution competition ELISA.通过在溶液竞争酶联免疫吸附测定中允许无限制的特异性相互作用来检测类似病毒衣壳蛋白中的细微差异。
J Virol Methods. 2016 Oct;236:1-4. doi: 10.1016/j.jviromet.2016.06.007. Epub 2016 Jun 16.
8
Identification of a Critical and Conformational Neutralizing Epitope in Human Adenovirus Type 4 Hexon.人4型腺病毒六邻体中关键且构象性中和表位的鉴定
J Virol. 2018 Jan 2;92(2). doi: 10.1128/JVI.01643-17. Print 2018 Jan 15.
9
Adenovirus serotype 5 neutralizing antibodies target both hexon and fiber following vaccination and natural infection.腺病毒血清型 5 中和抗体在接种疫苗和自然感染后靶向六邻体和纤维。
J Virol. 2012 Jan;86(1):625-9. doi: 10.1128/JVI.06254-11. Epub 2011 Nov 9.
10
A capture enzyme-linked immunosorbent assay for virus infectivity titrations as exemplified in an adenovirus system.一种用于病毒感染性滴定的捕获酶联免疫吸附测定法,以腺病毒系统为例。
J Immunoassay. 1993 Mar-Jun;14(1-2):1-19. doi: 10.1080/15321819308019837.

引用本文的文献

1
The seroprevalence of adenoviruses since 2000.2000年以来腺病毒的血清流行率。
Emerg Microbes Infect. 2025 Dec;14(1):2475831. doi: 10.1080/22221751.2025.2475831. Epub 2025 Mar 17.
2
Adenoviral Vector System: A Comprehensive Overview of Constructions, Therapeutic Applications and Host Responses.腺病毒载体系统:构建、治疗应用和宿主反应的全面概述。
J Microbiol. 2024 Jul;62(7):491-509. doi: 10.1007/s12275-024-00159-4. Epub 2024 Jul 22.
3
The Immune System-A Double-Edged Sword for Adenovirus-Based Therapies.免疫系统——腺病毒疗法的双刃剑。
Viruses. 2024 Jun 17;16(6):973. doi: 10.3390/v16060973.
4
Neutralizing monoclonal antibodies protect against human adenovirus type 55 infection in transgenic mice and tree shrews.中和单克隆抗体可预防转基因小鼠和树鼩感染人 55 型腺病毒。
Emerg Microbes Infect. 2024 Dec;13(1):2307513. doi: 10.1080/22221751.2024.2307513. Epub 2024 Feb 1.
5
Significance of Preexisting Vector Immunity and Activation of Innate Responses for Adenoviral Vector-Based Therapy.腺病毒载体治疗中预先存在的载体免疫和固有免疫反应激活的意义。
Viruses. 2022 Dec 6;14(12):2727. doi: 10.3390/v14122727.
6
Therapeutic Implementation of Oncolytic Viruses for Cancer Immunotherapy: Review of Challenges and Current Clinical Trials.溶瘤病毒在癌症免疫治疗中的治疗应用:挑战与当前临床试验综述
J Biomed Sci Res. 2022;4(2). doi: 10.36266/JBSR/164. Epub 2022 Oct 20.
7
Role of Adenoviruses in Cancer Therapy.腺病毒在癌症治疗中的作用。
Front Oncol. 2022 Jun 9;12:772659. doi: 10.3389/fonc.2022.772659. eCollection 2022.
8
Adenovirus entry: Stability, uncoating, and nuclear import.腺病毒进入:稳定性、脱壳和核输入。
Mol Microbiol. 2022 Oct;118(4):309-320. doi: 10.1111/mmi.14909. Epub 2022 Apr 26.
9
Nonreplicating Adenoviral Vectors: Improving Tropism and Delivery of Cancer Gene Therapy.非复制型腺病毒载体:改善癌症基因治疗的靶向性与递送
Cancers (Basel). 2021 Apr 14;13(8):1863. doi: 10.3390/cancers13081863.
10
Current strategies to circumvent the antiviral immunity to optimize cancer virotherapy.规避抗病毒免疫以优化癌症病毒疗法的当前策略。
J Immunother Cancer. 2021 Apr;9(4). doi: 10.1136/jitc-2020-002086.

本文引用的文献

1
Mechanism of adenovirus neutralization by Human alpha-defensins.人α-防御素对腺病毒的中和机制。
Cell Host Microbe. 2008 Jan 17;3(1):11-9. doi: 10.1016/j.chom.2007.12.001.
2
Abrupt emergence of diverse species B adenoviruses at US military recruit training centers.美国军事新兵训练中心出现多种B型腺病毒的突然暴发。
J Infect Dis. 2007 Nov 15;196(10):1465-73. doi: 10.1086/522970. Epub 2007 Oct 31.
3
Genotype prevalence and risk factors for severe clinical adenovirus infection, United States 2004-2006.2004 - 2006年美国严重临床腺病毒感染的基因型流行情况及危险因素
Clin Infect Dis. 2007 Nov 1;45(9):1120-31. doi: 10.1086/522188. Epub 2007 Sep 27.
4
Neutralization of animal virus infectivity by antibody.抗体对动物病毒感染性的中和作用。
Arch Virol. 2007;152(6):1047-59. doi: 10.1007/s00705-006-0923-8. Epub 2007 Feb 15.
5
PU.1 redirects adenovirus to lysosomes in alveolar macrophages, uncoupling internalization from infection.PU.1将腺病毒重定向至肺泡巨噬细胞中的溶酶体,使内化与感染脱钩。
J Immunol. 2007 Feb 15;178(4):2440-7. doi: 10.4049/jimmunol.178.4.2440.
6
Visualization of alpha-helices in a 6-angstrom resolution cryoelectron microscopy structure of adenovirus allows refinement of capsid protein assignments.在腺病毒6埃分辨率的冷冻电子显微镜结构中对α-螺旋的可视化,有助于优化衣壳蛋白的分配。
J Virol. 2006 Dec;80(24):12049-59. doi: 10.1128/JVI.01652-06. Epub 2006 Sep 27.
7
Adenovirus core protein pVII is translocated into the nucleus by multiple import receptor pathways.腺病毒核心蛋白pVII通过多种输入受体途径转运至细胞核。
J Virol. 2006 Oct;80(19):9608-18. doi: 10.1128/JVI.00850-06.
8
A superhighway to virus infection.一条通向病毒感染的超级高速公路。
Cell. 2006 Feb 24;124(4):741-54. doi: 10.1016/j.cell.2006.02.018.
9
Adenovirus receptors.腺病毒受体
J Virol. 2005 Oct;79(19):12125-31. doi: 10.1128/JVI.79.19.12125-12131.2005.
10
Neutralizing antibodies to adenovirus serotype 5 vaccine vectors are directed primarily against the adenovirus hexon protein.针对5型腺病毒疫苗载体的中和抗体主要针对腺病毒六邻体蛋白。
J Immunol. 2005 Jun 1;174(11):7179-85. doi: 10.4049/jimmunol.174.11.7179.

中和抗体通过阻止微管依赖性细胞质运输来阻断腺病毒感染。

Neutralizing antibody blocks adenovirus infection by arresting microtubule-dependent cytoplasmic transport.

作者信息

Smith Jason G, Cassany Aurelia, Gerace Larry, Ralston Robert, Nemerow Glen R

机构信息

Department of Immunology and Microbial Science, The Scripps Research Institute, 10550 N. Torrey Pines Rd., La Jolla, CA 92037, USA.

出版信息

J Virol. 2008 Jul;82(13):6492-500. doi: 10.1128/JVI.00557-08. Epub 2008 Apr 30.

DOI:10.1128/JVI.00557-08
PMID:18448546
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2447115/
Abstract

Neutralizing antibodies are commonly elicited by viral infection. Most antibodies that have been characterized block early stages of virus entry that occur before membrane penetration, whereas inhibition of late stages in entry that occurs after membrane penetration has been poorly characterized. Here we provide evidence that the neutralizing antihexon monoclonal antibody 9C12 inhibits adenovirus infection by blocking microtubule-dependent translocation of the virus to the microtubule-organizing center following endosome penetration. These studies identify a previously undescribed mechanism by which neutralizing antibodies block virus infection, a situation that may be relevant for other nonenveloped viruses that use microtubule-dependent transport during cell entry.

摘要

中和抗体通常由病毒感染引发。大多数已被鉴定的抗体可阻断病毒进入细胞的早期阶段,这些阶段发生在膜穿透之前,而对于膜穿透后发生的病毒进入后期阶段的抑制作用,目前了解甚少。在此,我们提供证据表明,中和性抗六邻体单克隆抗体9C12通过在内体穿透后阻断病毒依赖微管向微管组织中心的转运,从而抑制腺病毒感染。这些研究确定了一种以前未被描述的中和抗体阻断病毒感染的机制,这种情况可能与其他在细胞进入过程中利用微管依赖运输的非包膜病毒有关。